TRNT1
protein-codingtRNA nucleotidyl transferase 1
Gene summary
The protein encoded by this gene is a CCA-adding enzyme which belongs to the tRNA nucleotidyltransferase/poly(A) polymerase family. This essential enzyme functions by catalyzing the addition of the conserved nucleotide triplet CCA to the 3' terminus of tRNA molecules. Mutations in this gene result in sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~26.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014850
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014487
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014487
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0014487
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014487
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014850
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014487
Submitter: ClinGen
Per Criteria outlined by the ClinGen Lumping and Splitting working group, we found no difference in molecular mechanism or inheritance pattern underlying the disease entities: (1) Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD), (MIM:616084) and (2) Retinitis pigmentosa and erythrocytic microcytosis, (MIM:616959). Therefore, evidence favor lumping the entities (MIM:616084 and MIM:616959) to a single disease spectrum. TRNT1 (CCA-adding tRNA nucleotidyl transferase enzyme) performs an essential post- transcriptional modification by adding on the cytosine- cytosine-adenine (CCA) trinucleotide sequence to the 3′ end of all newly produced tRNAs. This TRNT1- dependent tRNA modification is essential for both cytosolic and mitochondrial tRNAs (mt-tRNAs) to participate in protein biosynthesis. Mutations in *TRNT1* were first reported to cause a syndrome characterized by congenital sideroblastic anemia, B-cell immunodeficiency, recurrent fevers and developmental delay (referred to as SIFD) in 2014 (PMID: 25193871). Retinitis pigmentosa and erythrocytic microcytosis were also reported in SIFD patients (PMID: 27370603). 2 frameshift , 2 splicing , and 3 missense TRNT1 variants are used in this curation. Mechanism of pathogenicity seems to be loss of function resulting in impaired ability of TRNT1 to catalyze the formation of the CCA trinucleotide (PMID: 25193871) Experimental evidence also supports this gene-disease relationship. Phenotypes of the lumped diseases could be recapitulated in Zebrafish model system through the same molecular pathway. Morphological analysis of the MO-injected embryos (morphants) revealed cardiovascular defects and reduced eye size in addition to reduced staining of hemoglobin-containing red blood cells and significantly reduced touch response. RNA sequencing confirmed that Morphants had a significantly lower CCA incorporation efficiency than controls (PMID: 26494905). Mt-tRNAs lacking CCA are also detected in patients’ fibroblasts compared to controls (PMID: 27370603). In summary, *TRNT1* is definitively associated with the disease spectrum Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) and Retinitis pigmentosa and erythrocytic microcytosis. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Antibody Deficiencies GCEP on October 7, 2022.
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Hematologic; Neurologic; Ophthalmologic; Renal
Intervention: Allergy/Immunology/Infectious; Audiologic/Otolaryngologic; Hematologic
Rationale: Medical management (with immunoglobulin therapy) has been described as beneficial; Most patients have been described as requiring regular blood transfusions for treatment of anemia, as well as iron chelation; Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; BMT has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TRNT1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_182916.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 113 | 1 | 120 | ||
| missense | 4 | 8 | 266 | 11 | 1 | 290 |
| nonsense | 9 | 4 | 1 | 14 | ||
| start loss | 1 | 1 | ||||
| frameshift | 44 | 12 | 3 | 1 | 60 | |
| splice donor/acceptor (+/-2bp) | 2 | 6 | 5 | 13 | ||
| Total | 59 | 30 | 282 | 125 | 2 | 498 |
Highest pathogenic variant AF is 0.00024112935
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_886552.3 | 7 | MANE Select | |
| Ensembl | ENSP00000251607.6 | 7 | MANE Select | |
| RefSeq | NP_001289875.2 | 7 | Standard | |
| RefSeq | NP_001354250.1 | 7 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| trnt1 | Danio rerio | Structure: neuromast hair cell Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- RNA transport - Homo sapiens (human)
- tRNA processing
- Metabolism of RNA
- tRNA processing in the mitochondrion
- tRNA processing in the nucleus
Biological Process
- tRNA 3'-terminal CCA addition
- tRNA 3'-end processing
- mitochondrial tRNA 3'-end processing
Molecular Function
- tRNA binding
- ATP binding
- 5'-3' RNA polymerase activity
- CTP:tRNA cytidylyltransferase activity
- CTP:3'-cytidine-tRNA cytidylyltransferase activity
Cellular Component
- nucleoplasm
- mitochondrion
- mitochondrial matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000251607
- Coding exons
- 7
- Length
- 23964
- Individuals with no LoFs
- 125615
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 133
- Defined
- 125748
- p
- 0.000529
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.15 | 273 | 225 | 1.22 | 0.0000109 | 2865 |
| Missense (PolyPhen) | 81 | 72.514 | 1.117 | 874 | ||
| Synonymous | 0.244 | 76 | 78.8 | 0.965 | 0.00000390 | 786 |
| Loss of Function | 1.95 | 9 | 17.9 | 0.502 | 7.48e-7 | 255 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00038 | 0.00037 | rare |
| Latino/Admixed American | 0.00063 | 0.00061 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00051 | 0.00049 | rare |
| Finnish | 0.00038 | 0.00037 | rare |
| European (Non-Finnish) | 0.00071 | 0.00069 | rare |
| South Asian | 0.00039 | 0.00036 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Isoform 1: Adds and repairs the conserved 3'-CCA sequence necessary for the attachment of amino acids to the 3' terminus of tRNA molecules, using CTP and ATP as substrates. {ECO:0000269|PubMed:11504732}.;
- Disease
- DISEASE: Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD) [MIM:616084]: An autosomal recessive disease characterized by severe sideroblastic anemia with onset in the neonatal period or infancy, recurrent periodic fevers without an infectious etiology, B-cell lymphopenia and hypogammaglobulinemia. Affected individuals show delayed psychomotor development with variable neurodegeneration. Additional variable features include sensorineural hearing loss, retinitis pigmentosa, nephrocalcinosis, and cardiomyopathy. {ECO:0000269|PubMed:25193871}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa and erythrocytic microcytosis (RPEM) [MIM:616959]: An autosomal recessive disease characterized by retinitis pigmentosa, red blood cell microcytosis and anisocytosis with mild anemia. {ECO:0000269|PubMed:26494905}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- LoFtool
- 0.899
- RVIS EVS
- -0.6
- RVIS percentile EVS
- 17.91
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.808
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |